N-[2-HYDROXY-3-(1-PIPERIDINYL)PROPOXY]PYRIDIN-1-OXID-3-CARBOXIMIDOYL CHLORID UND SEINE VERWENDUNG ALS MITTEL ZUR BEHANDLUNG VON INSULINRESISTENZ

N-[2-HYDROXY-3-(1-PIPERIDINYL)PROPOXY]PYRIDIN-1-OXID-3-CARBOXIMIDOYL CHLORID UND SEINE VERWENDUNG ALS MITTEL ZUR BEHANDLUNG VON INSULINRESISTENZ

N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and patholog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOMAROMI, ANDRAS, KARDOS, MIHALYNE, NAGY, KAROLY, UEROEGDI, LASZLO, H-6090 KUNSZENTMIKLOS, MARVANYOS, EDE, NAGY, MELINDA, SZILBEREKY, JENO, KUERTHY, MARIA, CSAKAI, ZITA, MOGYOROSI, TAMAS, BIRO, KATALIN, KORANYI, LASZLO, TOEROEK, MAGDOLNA, BARABAS, MIHALY, NAGY, ZOLTAN
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.